Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy D Sanderson

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Gastroenterology|August 28, 2015
TPMT Testing Before Starting Azathioprine or Mercaptopurine: Surely Just Do It?Jeremy D Sanderson
The Lancet. Infectious Diseases|March 28, 2009
The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoeaGareth C Parkes, Jeremy D Sanderson, Kevin Whelan
Pharmacogenomics|March 19, 2010
Pharmacogenomics in the treatment of inflammatory bowel diseaseMelissa A Smith, Anthony M Marinaki, Jeremy D Sanderson
Journal of Crohn'S & Colitis|June 8, 2013
Alopecia areata: a possible extraintestinal manifestation of Crohn's diseaseKamal V Patel, Jeremy D Sanderson, Peter M Irving
Gastroenterology|October 10, 2017
A Case of Unusual Ileal DiscolorationAngad S Dhillon, Emma L Johnston, Jeremy D Sanderson
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 29, 2020
ReplyNatalie J Prescott, Kirstin M Taylor, Jeremy D Sanderson
Journal of Crohn'S & Colitis|November 26, 2013
Oesophageal Crohn's disease: a novel approach to managing iatrogenic perforation of an oesophageal Crohn's strictureKamal V Patel, Peter M Irving, Jeremy D Sanderson
Journal of Crohn'S & Colitis|December 10, 2013
Reply to Dr. Marques do Santos' letter - should we treat asymptomatic patients with mildly ulcerated terminal ileum?Kamal V Patel, Simon H Anderson, Jeremy D Sanderson
European Journal of Gastroenterology & Hepatology|June 1, 2012
Anti-infliximab antibodies in inflammatory bowel disease: prevalence, infusion reactions, immunosuppression and response, a meta-analysisLennard Y W Lee, Jeremy D Sanderson, Peter M Irving
The American Journal of Gastroenterology|June 3, 2008
Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatmentGareth C Parkes, Jonathan Brostoff, Kevin Whelan, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Gastroenterology|August 28, 2015
TPMT Testing Before Starting Azathioprine or Mercaptopurine: Surely Just Do It?Jeremy D Sanderson
The Lancet. Infectious Diseases|March 28, 2009
The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoeaGareth C Parkes, Jeremy D Sanderson, Kevin Whelan
Pharmacogenomics|March 19, 2010
Pharmacogenomics in the treatment of inflammatory bowel diseaseMelissa A Smith, Anthony M Marinaki, Jeremy D Sanderson
Journal of Crohn'S & Colitis|June 8, 2013
Alopecia areata: a possible extraintestinal manifestation of Crohn's diseaseKamal V Patel, Jeremy D Sanderson, Peter M Irving
Gastroenterology|October 10, 2017
A Case of Unusual Ileal DiscolorationAngad S Dhillon, Emma L Johnston, Jeremy D Sanderson
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 29, 2020
ReplyNatalie J Prescott, Kirstin M Taylor, Jeremy D Sanderson
Journal of Crohn'S & Colitis|November 26, 2013
Oesophageal Crohn's disease: a novel approach to managing iatrogenic perforation of an oesophageal Crohn's strictureKamal V Patel, Peter M Irving, Jeremy D Sanderson
Journal of Crohn'S & Colitis|December 10, 2013
Reply to Dr. Marques do Santos' letter - should we treat asymptomatic patients with mildly ulcerated terminal ileum?Kamal V Patel, Simon H Anderson, Jeremy D Sanderson
European Journal of Gastroenterology & Hepatology|June 1, 2012
Anti-infliximab antibodies in inflammatory bowel disease: prevalence, infusion reactions, immunosuppression and response, a meta-analysisLennard Y W Lee, Jeremy D Sanderson, Peter M Irving
The American Journal of Gastroenterology|June 3, 2008
Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatmentGareth C Parkes, Jonathan Brostoff, Kevin Whelan, et al.
Pageof 7